RFamide-related peptide (RFRP) is a pivotal neuropeptide implicated in the modulation of various physiological processes, including but not limited to, stress response, reproductive function, and feeding behavior. The RFRP gene encodes a precursor polypeptide that is subsequently cleaved to produce the active neuropeptide, which then interacts with G protein-coupled receptors to exert its biological effects. The expression of RFRP is finely tuned by a complex network of signaling pathways that respond to an array of intracellular and extracellular cues. Understanding the regulation of RFRP expression is critical, as it provides insight into the intricate mechanisms that balance physiological homeostasis and adaptability to environmental challenges.
Several chemicals have the potential to act as activators of RFRP expression, exerting their effects through diverse molecular mechanisms. Compounds such as retinoic acid and beta-estradiol may stimulate RFRP transcription by binding to their respective receptors, which then interact with the regulatory regions of the RFRP gene to upregulate its expression. On the other hand, epigenetic modifiers like Trichostatin A (TSA) and 5-Azacytidine could potentially induce transcriptional activation of RFRP by altering the chromatin landscape, making the DNA more accessible for transcription factors. Forskolin is another example; it raises intracellular cAMP levels, leading to the activation of protein kinase A and subsequent phosphorylation of transcription factors that may enhance RFRP gene expression. Additionally, compounds such as Vitamin D3 can also play a role in the transcriptional regulation of RFRP by binding to the vitamin D receptor, which may interact with vitamin D response elements in the RFRP gene promoter. While the effects of these chemicals on RFRP expression are supported by known interactions within cellular signaling pathways, the direct influence on RFRP requires empirical confirmation. Understanding the ability of these chemicals to act as activators of RFRP expression expands our knowledge of the regulatory networks governing this neuropeptide and highlights the complexity of gene expression regulation at the molecular level.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate RFRP by binding to retinoic acid receptors that control the transcription of developmental genes, potentially modifying neuronal circuits or hormonal pathways that govern the expression of genes such as RFRP. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, can open up chromatin architecture, creating a favorable environment for the transcription machinery to access the RFRP gene promoter and stimulate its expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can induce the demethylation of DNA, possibly leading to the reactivation of epigenetically silenced genes. The increased accessibility of transcription factors to the RFRP promoter may result in higher levels of RFRP transcripts. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP, Forskolin can activate PKA and subsequent transcription factors which may enhance the transcriptional activity of the RFRP gene, leading to increased RFRP peptide synthesis. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This hormone can bind estrogen receptors, which may directly bind to estrogen response elements on the RFRP gene promoter, leading to the transcriptional activation and increased synthesis of RFRP. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a synthetic glucocorticoid, Dexamethasone can stimulate the glucocorticoid response elements in certain genes. This stimulation could extend to the RFRP gene, promoting its expression in response to stress. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate can induce histone hyperacetylation, thereby decreasing chromatin compaction. This change may enhance the accessibility of transcription factors to the RFRP gene, leading to its increased transcription. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline can disrupt mitochondrial protein synthesis, which may trigger compensatory mechanisms in cellular metabolism potentially involving pathways that upregulate RFRP expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can stimulate the Wnt signaling pathway, which might lead to the activation of gene transcription factors that increase RFRP expression as part of the cellular adaptation to Wnt pathway modulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate PKC, leading to the activation of downstream transcription factors and the subsequent transcriptional upregulation of genes like RFRP, particularly in neuronal cells where PKC is prominent. | ||||||